NASDAQ:ITUS ITUS (ITUS) Stock Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free ITUS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.61▼$4.7650-Day Range N/A52-Week Range$1.83▼$6.43Volume69,859 shsAverage Volume134,373 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get ITUS alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About ITUS Stock (NASDAQ:ITUS)Anixa Biosciences, Inc. is a cancer-focused biotechnology company, which focuses on harnessing the body's immune system in the fight against cancer. It operates through the following segments: Cancer Diagnostics, Cancer Therapeutics, and Legacy Patent Licensing Activities. Cancer Diagnostic segment develops CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body's immune response to the presence of a malignancy. Cancer Therapeutics segment offers chimeric antigen receptor T-cell (CAR-T) based immune-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.Read More Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here ITUS Stock News HeadlinesApril 22, 2024 | msn.comBuilt by 'Bama: Nick and Terry Saban help build 21st Habitat houseApril 7, 2024 | msn.comClear skies for your SundayApril 24, 2024 | DTI (Ad)the harsh reality of the stock marketOK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth.April 6, 2024 | msn.comCool temperatures expected for your SaturdayApril 5, 2024 | msn.comHexagon acquires Virginia-based Itus DigitalApril 4, 2024 | finanznachrichten.deHexagon rebrands Qognify, reaffirming commitment to physical securityApril 4, 2024 | finance.yahoo.comHexagon acquires Itus Digital to expand Asset Performance Management capabilitiesApril 2, 2024 | msn.comStellenbosch cement second spot with victory over Kaizer ChiefsApril 24, 2024 | DTI (Ad)the harsh reality of the stock marketOK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth.March 27, 2024 | msn.comMan arrested in Titus County sex sting operationMarch 23, 2024 | nasdaq.comMay 3rd Options Now Available For Eli Lilly (LLY)March 18, 2024 | msn.comSome bay clouds Monday with sunny and warm afternoonMarch 17, 2024 | msn.comSunny skies for your SundayMarch 11, 2024 | msn.com"A kit with some surprising tricks up its sleeve": Donner Backbeat reviewMarch 9, 2024 | msn.comFactChecking Biden’s State of the UnionMarch 7, 2024 | msn.comSeven candidates for three seats on 5th District Court of Appeals, in all-GOP affairFebruary 21, 2024 | msn.comITU's AI for Good Global Summit 2024 puts tech to the test for people and planetFebruary 19, 2024 | msn.comChapel Hill ISD announces $9.3 million bond election for MayFebruary 13, 2024 | msn.comUS Senate Passes Ukraine Aid Bill, House Likely To Reject ItFebruary 6, 2024 | ft.comLetter: One way to raise quality of classroom discussionsJanuary 26, 2024 | msn.comSeasonably cool Thursday with sunshineJanuary 14, 2024 | msn.com‘Your Tahoe needs a tune up buddy’: Man who taunted police after escaping dangerous chase busted by his own Snapchat braggingJanuary 13, 2024 | msn.com'Your Tahoe needs a tune up buddy': Man who taunted police after escaping dangerous chase busted by his own Snapchat braggingJanuary 10, 2024 | theglobeandmail.comItus Mouthguardz Earns Global Acclaim for USA Patented Anti-Snore DeviceJanuary 10, 2024 | msn.comScattered showers for your WednesdayJanuary 8, 2024 | msn.comOpinion: Maybe it’s time for me to just accept my geezerhood?December 24, 2023 | msn.comChilly weather for the holidaysSee More Headlines Receive ITUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ITUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/09/2018Today4/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Patent Owners & Lessors Sub-IndustryN/A Current SymbolNASDAQ:ITUS CUSIPN/A CIK715446 Webwww.ituscorp.com Phone(408) 708-9808FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesAmit D. KumarExecutive Chairman, President & CEOMichael J. CatelaniSecretary, Chief Operating & Financial OfficerThomas SchlumpbergerExecutive Vice President-DiagnosticsKey CompetitorsFull Truck AllianceNYSE:YMMFutuNASDAQ:FUTUIntegrated Media TechnologyNASDAQ:IMTEOnion GlobalNYSE:OGBLYRenovare EnvironmentalNASDAQ:RENOView All Competitors ITUS Stock Analysis - Frequently Asked Questions How were ITUS's earnings last quarter? ITUS Co. (NASDAQ:ITUS) released its quarterly earnings results on Friday, March, 9th. The business services provider reported ($0.11) EPS for the quarter. What other stocks do shareholders of ITUS own? Based on aggregate information from My MarketBeat watchlists, some companies that other ITUS investors own include Synergy Pharmaceuticals (SGYP), Galectin Therapeutics (GALT), Progenics Pharmaceuticals (PGNX), Catalyst Pharmaceuticals (CPRX), Halozyme Therapeutics (HALO), Palatin Technologies (PTN), Advanced Micro Devices (AMD), Coherus BioSciences (CHRS) and CME Group (CME). This page (NASDAQ:ITUS) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressPentagon contract could send this $2 AI stock soaringBehind the MarketsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ITUS Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
